Within CD Formulation's Nucleic Acid Drug Sequencing Technology Platform, we utilize the latest high-throughput sequencing tools to perform detailed analysis of DNA and RNA sequences. This approach not only unlocks diverse possibilities for scientific research and development, but also ensures that sequencing is both efficient and budget-friendly. Our platform is equipped with cutting-edge technology, guaranteeing that users receive dependable sequencing results at an affordable price.
Fig.1 Advantages of nucleic acid sequencing technology. (CD Formulation)
Items | Principle | Characteristics |
---|---|---|
tNGS (Targeted Sequencing) Platform | tNGS is a sequencing method that merges ultra-multiplex PCR or targeted capture with high-throughput sequencing. It involves using specific primers or probes to amplify or capture nucleic acids from a sample, sequencing the target fragments obtained, and conducting bioinformatics analysis for sensitive and high-resolution nucleic acid identification. |
|
mNGS (Metagenomic Sequencing) Platform | mNGS involves rapidly determining the nucleic acid sequence in a sample using a second-generation sequencing platform and comparing it with known species' genome sequences. This technique identifies the types and proportions of microorganisms in the sample. A notable feature of mNGS is that it does not require clinical pre-judgment and can unbiasedly detect all microorganisms within a sample. |
|
DNA sequencing is a complex technology involving several key steps. First, DNA is extracted and purified from an organism. Next, free DNA bases, DNA primers, fluorescently labeled terminator bases, and DNA polymerase are added to a container. Through a series of heating and cooling cycles, a library of small DNA sequences is generated, each ending with a fluorescently labeled terminator base. The newly created DNA chains are then separated by length, with fluorescence signals excited by a laser and captured by a camera. Finally, a computer assembles the collected information into a full-length DNA sequence.
RNA sequencing involves a series of specialized steps. Initially, RNA is extracted, followed by the enrichment of mRNA to obtain the necessary template. Subsequently, a sequencing library is constructed and loaded onto sequencing equipment. Lastly, the resulting data is analyzed and interpreted to reveal RNA expression information and its role in gene regulation.
CD Formulation's sequencing platform enables in-depth analysis of nucleic acid drugs, concentrating on sequence accuracy and structural insights. Our services guarantee precision and stability in nucleic acid formulations, offering vital tools for researchers in biopharmaceuticals.
Technology: Next Generation Sequencing (NGS) Platforms for Nucleic Acid Sequence Analysis
Journal: Cells
IF: 7.666
Published: 2023
Results:
Targeted sequencing (TS) has become a vital technology in both clinical and research settings, with benefits such as high confidence and precision, reasonable processing times, affordability, minimal data requirements, and significant computational engagement. Due to the absence of universally agreed guidelines for the diverse next-generation sequencing (NGS) platforms and techniques, there's an urgent demand for developing effective strategies for molecular disease diagnostics, especially during health emergencies and global events like the COVID-19 pandemic. This review aims to summarize various TS methods, detail the design parameters of TS assays, describe different TS panels, address their limitations, and highlight the challenges of applying TS in the molecular analysis of human conditions.
Fig.2 General workflow of a NGS experiment. (Pei X M, et al., 2023)
At CD Formulation, our Nucleic Acid Drug Sequencing Technology Platform offers precise and detailed analysis for nucleic acid drug development. We emphasize sequence accuracy and structural insights, helping researchers progress with confidence. Contact us, and our advanced equipment and expert team are here to support innovative projects.
References